2QC-67522-49249
1 vaccination
1 coded response
5 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 210 / MD
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-16
-
2021-07-14
Survey response — 6 months, dose 1MedDRA: Anxiety, Perinatal depression — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Post partial depression and anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-20
- 2022-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-14 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Symptoms: Post partial depression and anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Depression | ○ | ○ | ○ |
| SD | Perinatal depression | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release